Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients.

Dorota Kamińska Hanna Augustyniak-Bartosik Katarzyna Kościelska-Kasprzak Marcelina ŻabińskaDorota BartoszekPaweł PoznańskiMagdalena Kuriata-KordekMariusz Andrzej Kusztal Oktawia MazanowskaMagdalena Krajewska

Published in: Journal of clinical medicine (2021)

HD patients and KTR develop humoral and cellular responses after COVID-19. The antibodies levels are similar in both groups of patients. SARS-CoV-2-reactive T cell response is stronger in HD patients compared to KTR. The SARS-CoV-2-specific IgG level decreases with time while IgA and a cellular response are maintained. IGRA proved to be a valuable test for the assessment of specific cellular immunity in immunocompromised HD patients and KTR.

Keyphrases

sars cov
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
immune response
coronavirus disease
intensive care unit
acute respiratory distress syndrome